EUVIMEDEUVIMED entdecken
Crossref

MCM10 modulates lipid metabolic reprogramming via the USP7-FASN axis to accelerate renal cell carcinoma progression

Ashuai Du, Kehua Jiang, Kai Li, Xinpei Deng, Dongbo Yuan, Yuanyuan Luo, Songsong Tan, Xuchao Dai, Bo Yu, Bo Yan, Huichao Huang, Junjie Xu und 2 weitere

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218842 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Ashuai Du und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection, Guizhou Provincial People's Hospital, Guiyang, 550000, China; Guangzhou Medical University, Guangzhou, 511495, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Ubiquitin-Specific Peptidase 7, Lipid Metabolism. Die Arbeit nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Health Commission of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming, particularly dysregulated lipid metabolism, is a hallmark of clear cell renal cell carcinoma (ccRCC) progression. However, the upstream regulators responsible for lipid metabolic rewiring remain largely unknown. Here, we integrated single-cell RNA sequencing, spatial transcriptomics, and functional validation to identify MCM10 as a critical regulator of lipid metabolism in ccRCC. Single-cell and spatial analyses revealed that MCM10 was predominantly expressed in malignant epithelial cells and positively associated with lipid metabolic activity and poor clinical outcomes. Functional studies demonstrated that MCM10 promoted ccRCC cell proliferation, migration, and lipid accumulation in vitro and enhanced tumor growth and metastasis in vivo. Mechanistically, MCM10 interacted with c-Myc and increased its protein stability by facilitating USP7-mediated deubiquitination and suppressing FBW7-dependent ubiquitination. Stabilized c-Myc directly bound to the promoter region of fatty acid synthase (FASN) and transcriptionally activated FASN expression, thereby promoting de novo fatty acid synthesis and lipid metabolic reprogramming. Collectively, our study reveals a previously unrecognized role of MCM10 in regulating lipid metabolic remodeling through the USP7/c-Myc/FASN axis and provides new insights into the molecular mechanisms underlying ccRCC progression. These findings suggest that targeting the MCM10-mediated metabolic pathway may represent a potential therapeutic strategy for ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsUbiquitin-Specific Peptidase 7Lipid MetabolismFatty Acid Synthase, Type IMinichromosome Maintenance ProteinsHumansMetabolic ReprogrammingAnimalsProto-Oncogene Proteins c-mycMiceCell ProliferationCell Line, TumorDisease ProgressionGene Expression Regulation, NeoplasticCell Movement

Stichwörter der Autor:innen

FASNLipid metabolic reprogrammingMCM10Renal cell carcinomaSingle-cell transcriptomicsc-Myc

Substanzen

Ubiquitin-Specific Peptidase 7Fatty Acid Synthase, Type IProto-Oncogene Proteins c-mycMinichromosome Maintenance ProteinsUSP7 protein, humanFASN protein, humanMYC protein, human

Autor:innen und Institutionen

  • Department of Infection, Guizhou Provincial People's Hospital, Guiyang, 550000, China; Guangzhou Medical University, Guangzhou, 511495, China.
  • Department of Urology, Guizhou Provincial People's Hospital, Key Laboratory for Cancer Prevention and Treatment of Guizhou Province, Guiyang, 550000, China.
  • Guizhou University Medical College, Guiyang, 550025, China.
  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Zunyi Medical University, Zunyi, 563000, China.
  • Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University, Hunan, China.

Förderung

  • National Natural Science Foundation of China
  • Health Commission of Guizhou Province

Zitieren

APA

Du, A., Jiang, K., Li, K., Deng, X., Yuan, D., Luo, Y., Tan, S., Dai, X., Yu, B., Yan, B., Huang, H., Xu, J., Wang, Y., & Zhu, J. (2026). MCM10 modulates lipid metabolic reprogramming via the USP7-FASN axis to accelerate renal cell carcinoma progression. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218842

Vancouver

Du A, Jiang K, Li K, Deng X, Yuan D, Luo Y, et al. MCM10 modulates lipid metabolic reprogramming via the USP7-FASN axis to accelerate renal cell carcinoma progression. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218842

BibTeX
@article{Du2026,
  author = {Du, Ashuai and Jiang, Kehua and Li, Kai and Deng, Xinpei and Yuan, Dongbo and Luo, Yuanyuan and Tan, Songsong and Dai, Xuchao and Yu, Bo and Yan, Bo and Huang, Huichao and Xu, Junjie and Wang, Yanjun and Zhu, Jianguo},
  title = {MCM10 modulates lipid metabolic reprogramming via the USP7-FASN axis to accelerate renal cell carcinoma progression},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218842}
}
Kostenlos starten →